In the wake of the increase in Current Liabilities in the fourth quarter 2022, Quick Ratio fell to 0.29 below Evolutionary Genomics Inc average.

Within Medical Laboratories industry 41 other companies have achieved higher Quick Ratio than Evolutionary Genomics Inc in fourth quarter 2022. While Quick Ratio total ranking in the fourth quarter 2022 has deteriorated compared to the prior quarter from 2906 to 3702.

Explain Quick Ratio?
How much Cash & cash equivalents FNAM�s has?
What are FNAM�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

FNAM Quick Ratio	(Dec 31 2022) Q4	(Sep 30 2022) Q3	(Jun 30 2022) Q2	(Mar 31 2022) Q1	(Dec 31 2021) Q4
Y / Y Current Liabilities Change	10552.53 %	28.35 %	1267.04 %	1257.85 %	490.62 %
Y / Y Cash & cash equivalent Change	169.65 %	26.43 %	152583.5 %	968.38 %	-0.85 %
Quick Ratio MRQ	0.29	0.4	0.51	18.56	11.32
FNAM's Total Ranking	# 3702	# 2906	# 2927	# 213	# 345
Seq. Current Liabilities Change	5.27 %	8.25 %	3046.5 %	197.07 %	-98.73 %
Seq. Cash & cash equivalent Change	-24.62 %	-14.73 %	-13.86 %	387.03 %	-64.66 %

Quick Ratio fourth quarter 2022 Company Ranking
Within:	No.
Medical Laboratories Industry	# 42
Healthcare Sector	# 1040
Overall Market	# 3702

Quick Ratio Statistics
High	Average	Low
226.18	36.44	0
(Jun 30 2018)		(Sep 30 2014)

Financial Statements
Evolutionary Genomics Inc 's Current Liabilities	$ 2 Millions	Visit FNAM's Balance sheet
Evolutionary Genomics Inc 's Cash & cash equivalent	$ 1 Millions	Visit FNAM's Balance sheet
Source of FNAM's Sales		Visit FNAM's Sales by Geography

Cumulative Evolutionary Genomics Inc 's Quick Ratio

FNAM's Quick Ratio for the trailling 12 Months

FNAM Quick Ratio	(Dec 31 2022) 12 Months	(Sep 30 2022) 12 Months	(Jun 30 2022) 12 Months	(Mar 31 2022) 12 Months	(Dec 31 2021) 12 Months
Y / Y Current Liabilities TTM Growth	250.02 %	130.79 %	1472.5 %	542.85 %	317.86 %
Y / Y Cash & cash equivalent TTM Growth	257.73 %	217.53 %	292.56 %	148.21 %	32.39 %
Quick Ratio TTM	0.57	0.78	0.83	1.1	0.56
Total Ranking TTM	# 3285	# 134	# 850	# 4300	# 4535
Seq. Current Liabilities TTM Growth	53.13 %	12.68 %	96.64 %	3.17 %	0.97 %
Seq. Cash & cash equivalent TTM Growth	12.44 %	5.8 %	48.17 %	102.95 %	-0.2 %

Quick ratio ranking by company, industry and sector >> Back to FNAM Financial Strength Comparisons >> Go to Compare FNAM Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q4 2022 to $2.01 millions, cumulative Quick Ratio decreased to 0.57 below the Evolutionary Genomics Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 41 other companies have achieved higher Quick Ratio than Evolutionary Genomics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2022 from 134 to 3285.

Explain Quick Ratio?
How much Cash & cash equivalents FNAM�s has?
What are FNAM�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 42
Healthcare Sector	# 1040
Within the Market	# 3285

trailing twelve months Quick Ratio Statistics
High	Average	Low
226.18	36.44	0
(Jun 30 2018)		(Sep 30 2014)

Companies with similar Quick Ratio in the quarter ending Dec 31 2022, within Medical Laboratories Industry	Quick Ratio	Dec 31 2022 MRQ Cash & cash equivalent	Dec 31 2022 MRQ Current Liabilities
Nrc Health	0.72	$ 25.026 Millions	$ 34.974 Millions
Capforce Inc	0.70	$ 7.440 Millions	$ 10.592 Millions
Genetron Holdings Ltd	0.45	$ 25.556 Millions	$ 56.525 Millions
LUDWIG ENTERPRISES, INC.	0.38	$ 0.516 Millions	$ 1.342 Millions
Radnet Inc	0.38	$ 181.006 Millions	$ 470.867 Millions
Ge Healthcare Technologies Inc	0.36	$ 1,440.000 Millions	$ 3,977.000 Millions
Iqvia Holdings Inc	0.35	$ 1,309.000 Millions	$ 3,742.000 Millions
Akumin Inc	0.31	$ 59.424 Millions	$ 193.884 Millions
Evolutionary Genomics Inc	0.29	$ 0.577 Millions	$ 2.013 Millions
Fortrea Holdings Inc	0.28	$ 112.000 Millions	$ 405.600 Millions
Charles River Laboratories International inc	0.28	$ 233.912 Millions	$ 850.568 Millions
Fresh2 Group Ltd	0.23	$ 0.610 Millions	$ 2.602 Millions
Quest Diagnostics Inc	0.20	$ 315.000 Millions	$ 1,566.000 Millions
Luna Innovations Inc	0.19	$ 6.024 Millions	$ 31.091 Millions
Koninklijke Philips Nv	0.18	$ 1,561.280 Millions	$ 8,917.606 Millions
Inotiv Inc	0.15	$ 20.820 Millions	$ 136.127 Millions
Labcorp Holdings Inc	0.13	$ 320.600 Millions	$ 2,480.100 Millions
Icon Plc	0.10	$ 290.481 Millions	$ 2,885.521 Millions
Medpace Holdings Inc	0.08	$ 28.265 Millions	$ 340.741 Millions

Date modified: 2026-08-29T07:14:09+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.